Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?

Share:

Listens: 0

Dr. Baliga's Internal Medicine Podcasts

Miscellaneous


Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis? Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians References Frye BC, Meiss F, von Bubnoff D, Zissel G, Müller-Quernheim J. Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis. N Engl J Med. 2020;382(26):2573-2574. doi:10.1056/NEJMc2000343   Benitez R, Delgado-Maroto V, Caro M, et al. Vasoactive Intestinal Peptide Ameliorates Acute Myocarditis and Atherosclerosis by Regulating Inflammatory and Autoimmune Responses. J Immunol. 2018;200(11):3697-3710. doi:10.4049/jimmunol.1800122   Not Medical Advice or Opinion